By Alvin Philipose, DC, ICCP
SOT stands for Supportive Oligonucleotide Therapy. The RGCC lab refers to it as the Supportive Oligonucleotide Technique. It is a custom infusion made for one patient, based on that patient’s own blood test.
What an Oligonucleotide Is
An oligonucleotide is a short, lab-made strand of genetic code. In SOT, the strand is designed to match a specific genetic sequence the lab identified in your sample. The goal is for the strand to bind to that target sequence.
Why Every SOT Is Made for One Person
No two SOT infusions are the same. The lab first analyzes your blood through RGCC testing. It then designs a strand for the target found in your sample and produces it for you alone.
How SOT Connects to RGCC Testing
SOT always starts with an RGCC blood test. Without that test, there is nothing to design the infusion from. Read about RGCC testing in Oklahoma City.
Is SOT FDA-Approved?
No. SOT has not been evaluated or approved by the FDA. It is produced by RGCC’s laboratory outside the United States. We explain this, and what is and is not known about SOT, before you decide anything.
Who Asks Us About SOT
Patients from Oklahoma City and surrounding areas, including Tulsa, ask about SOT after researching it on their own. Many are dealing with long-lasting symptoms after an infection. Our job is to give you straight answers so you can make an informed choice.
Related Pages
- SOT therapy and RGCC testing in Oklahoma City
- The SOT process and timeline
- What to expect at your SOT infusion
- SOT and RGCC FAQ
- RGCC testing in Oklahoma City
Call 405-848-7246 to book a free 15-minute discovery call.
Disclaimer: SOT has not been evaluated or approved by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. Individual results vary, and no outcome is promised.